Wexford Capital »

Atara Biotherapeutics shares owned by Wexford Capital

Quarter-by-quarter ownership of Atara Biotherapeutics (ATRA) shares owned by Wexford Capital from 13F filings

Historical chart of Wexford Capital investment in Atara Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atara Biotherapeutics held by Wexford Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atara Biotherapeutics by Wexford Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $15k 30k 0.51

More positions owned by Wexford Capital

Mammoth Energy Svcs (TUSK)
International Seaways (INSW)
Nephros (NEPH)
Ishares Msci Aust Etf (EWA)
Ishares Msci Cda Etf (EWC)
Spdr Ser Tr Portfolio S&p600 (SPSM)
Cenovus Energy (CVE)
Stellantis SHS (STLA)
Cool Common Shares (CLCO)
Astrazeneca Sponsored Adr (AZN)
Silverbow Resources (SBOW)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Gold Tr Gold Shs (GLD)
Golar Lng SHS (GLNG)
Enterprise Products Partners (EPD)

View all positions for Wexford Capital

Top funds holding Atara Biotherapeutics

EcoR1 Capital
Redmile Group
Vanguard Group
UBS Group
AQR Capital Management
Millennium Management
Jpmorgan Chase & Co
D. E. Shaw & Co
Staley Capital Advisers
GSA Capital Partners
Jacobs Levy Equity Management
Charles Schwab Investment Management
Goldman Sachs Group
Bank of New York Mellon
Bnp Paribas Arbitrage, Snc

View all funds holding Atara Biotherapeutics